| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.04 |